Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Elise A. Olsen, Sean Whittaker, Eric C. Vonderheid et al.|Blood|2007Cited by 1.4k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A. Olsen, Eric C. Vonderheid, Sean Whittaker et al.|Journal of Clinical Oncology|2011Cited by 657
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia Scarisbrick, Henry K. Wong, Francine M. Foss et al.|Journal of Clinical Oncology|2015Cited by 419
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patientsJulia Scarisbrick, Andrew Bates, Pietro Quaglino et al.|British Journal of Dermatology|2018Cited by 235
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumPietro Quaglino, C. Ram‐Wolff, Milena Maule et al.|Annals of Oncology|2017Cited by 136